This Company May Be the Next to Cross the Coronavirus Vaccine Finish Line

The U.S. Food and Drug Administration soon may grant Emergency Use Authorization to a big pharma company's investigational coronavirus vaccine. And the company doesn't immediately plan to take a profit on sales. In this Motley Fool Live video recorded on Jan. 22, 2021, Healthcare and Cannabis Bureau Chief Corinne Cardina and Fool.com contributor Adria Cimino discuss why you may want to buy shares of this company -- but not for its position in the vaccine race.

Continue reading

Source Fool.com